nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast ca...
Published 1 year ago • 64 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
6:05
treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved pfs for ...
-
4:31
expert report on treatment with tumour-infiltrating lymphocytes (tils)
-
4:46
entinostat, nivolumab and ipilimumab in advanced her2-negative breast cancer
-
1:33
dr. sylvia adams on tumor-infiltrating lymphocytes in triple negative breast cancer
-
2:01
tumor infiltrating lymphocytes (tils) as a predictive biomarker in breast cancer
-
4:17
adaptive tonic trial of nivolumab combinations for breast cancer
-
6:13
lba3 - treatment with tumor-infiltrating lymphocytes versus ipilimumab for advanced melanoma
-
2:43
our achievements - tils or tumor infiltrating lymphocytes
-
5:25
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
3:43
tumor-infiltrating lymphocytes act as prognostic biomarkers in advanced breast cancer
-
20:43
investigational pd-l1–targeted immunotherapy safe for patients with triple-negative breast cancer
-
35:24
dr justin balko - "immunophenotyping tumor infiltrating lymphocytes in breast cancer from.."
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
3:24
dr. saurabh garg at moffitt scientific symposium 2023: poster no. 006
-
22:26
triple-negative breast cancer: what's new in treatment and research at mbc patient forum 2019
-
33:47
immunotherapy for triple negative breast cancer
-
1:07
neotrip: efs in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk tnbc
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer